We will be updating this page with articles on coronavirus from Gov.uk, PHE, DH&SC and the NHS
PHE plays crucial role in hunt for COVID-19 vaccine
The team has been awarded $500,000 by the US Food and Drug Administration (FDA) to bolster the international response to coronavirus vaccine and treatment development.
The funding comes as the Coalition for Epidemic Preparedness Innovations (CEPI) funds PHE to evaluate vaccines in their pipeline vaccine that are destined for clinical trials as early as April 2020.....
Health and Social Care Secretary Matt Hancock responds to NHS workforce statistics demonstrating an increase in nurses and doctors.
Compared to last year the number of nurses in the NHS has increased by 9,398 and the number of doctors has risen by 5,188, figures published today show.
In addition to this, as part of the ‘Your NHS Needs You’ recruitment drive, 15,266 former professionals in England have so far come forward to help the NHS tackle COVID-19 and will start being deployed from this weekend. This includes 5,117 doctors, 5,605 nurses and midwives and 3,686 allied health professionals and pharmacists.
Guidance for industry on evaluations of diagnostic products for coronavirus
Public Health England (PHE) has established a capability to evaluate approaches from industry to encourage diagnostic and other scientific innovation.
This programme, led by a joint team working across PHE’s Colindale and Porton Down scientific campuses and regional networks, will provide a single entry-point for all communication from industry and involves a two-stage rapid evaluation process, which is as follows.
Responding to COVID-19: the ethical framework for adult social care
The current novel coronavirus (COVID-19) outbreak, which began in December 2019, will have major implications for health and care services in the UK.
As set out in the coronavirus action plan, published on 3 March 2020, the UK’s health and social care systems have planned extensively over the years for a pandemic and are well prepared to offer substantial protection to the public. Of course, the exact response to COVID-19 will be tailored to the nature, scale and location of the threat as our understanding of this develops.....